FBXW7 and neoplasm: These findings were confirmed in a small set of human CRC samples (five tumor and six control samples) that confirmed increased Notch activity, suggesting that a failure to antagonize Notch activity is an evolutionarily conserved mechanism of loss of function of FBXW7 [43].